title: [Intrathecal chemotherapy in acute lymphoblastic leukemia. Prospective evaluation of toxicity using a combination employed in Mexico].
authors.forename: D
authors.initials: D
authors.lastname: Gómez-Almaguer
authors.forename: C
authors.initials: C
authors.lastname: Almaguer-Gaona
authors.forename: P
authors.initials: P
authors.lastname: Mora-Brondo
authors.forename: O
authors.initials: O
authors.lastname: González-Llano
authors.forename: J
authors.initials: J
authors.lastname: Marfil-Rivera
authors.forename: G
authors.initials: G
authors.lastname: Villarreal
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage / Q000009:adverse effects; D003907:Dexamethasone / Q000008:administration & dosage / Q000009:adverse effects; D004341:Drug Evaluation; D006261:Headache / Q000139:chemically induced; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007278:Injections, Spinal; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011446:Prospective Studies; D014839:Vomiting / Q000139:chemically induced
chemical_list: D003561:Cytarabine; D003907:Dexamethasone; D008727:Methotrexate
vernacular_title: Quimioterapia intratecal en leucemia aguda linfoblástica. Evaluación prospectiva de la toxicidad utilizando una combinación recomendable en México.